Sudhir Borgonha

Sudhir Borgonha

Directeur Général chez Translational Medicine India, Inc.

Health Technology
Commercial Services
Finance

Profil

Sudhir Borgonha was the founder of Ten3T Healthcare Pvt Ltd.
(founded in 2014) and held the title of Director.
Dr. Borgonha is also the founder of Angstrom Medica, Inc. Dr. Borgonha's current job is Chief Executive Officer at Translational Medicine India, Inc. since 2006 and Chief Executive Officer at ClinTest International.
Dr. Borgonha's former jobs include being the Medical Director at Martindale Pharmaceuticals Ltd.
from 2011 to 2012, Medical Director at Strand Genomics, Inc. from 2014 to 2018, and Vice President-Clinical Development at Capricor Therapeutics, Inc. Dr. Borgonha's education includes an undergraduate degree from Massachusetts Institute of Technology in 2001 and an undergraduate degree from St. John's Medical College in 1997.

Postes actifs de Sudhir Borgonha

SociétésPosteDébut
Directeur Général 01/01/2006
ClinTest International Directeur Général -
Tous les postes actifs de Sudhir Borgonha

Anciens postes connus de Sudhir Borgonha

SociétésPosteFin
Fondateur 01/01/2020
Directeur Technique/Scientifique/R&D 01/01/2018
Directeur Technique/Scientifique/R&D 01/01/2012
CAPRICOR THERAPEUTICS, INC. Directeur Technique/Scientifique/R&D -
Fondateur -
Voir l'expérience en détail de Sudhir Borgonha

Formation de Sudhir Borgonha

Massachusetts Institute of Technology Undergraduate Degree
St. John's Medical College Undergraduate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Sudhir Borgonha

Relations

100 +

Relations au 1er degré

9

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées1
CAPRICOR THERAPEUTICS, INC.

Health Technology

Entreprise privées6

Health Technology

Commercial Services

ClinTest International

Health Technology

Health Services

Technology Services

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Sudhir Borgonha